MIT launches Center for Multi-Cellular Engineered Living Systems
M-CELS are purpose-driven living systems with multiple interacting living components.
M-CELS are purpose-driven living systems with multiple interacting living components.
MIT researchers identify a molecule that could target advanced prostate cancer as well as a variety of other cancers.
Study suggests mechanical properties of spike proteins can predict infectivity and lethality of different coronaviruses.
Device could provide pressurized steam to run autoclaves without the need for electricity in off-grid areas.
Gelatin-based microcarriers offer higher yield and scalability compared to existing commercial microcarriers.
During her time at MIT, senior Ayesha Ng’s interests have expanded from cellular biology to the social systems that shape public health.
Machine learning model predicts probability that a particular urinary tract infection can be treated by specific antibiotics.
Results might provide a convenient screening tool for people who may not suspect they are infected.
MIT conference illustrates technologies developed in response to the pandemic and new opportunities for AI solutions for clinical management.
Immuneering uses bioinformatics to develop new medicines while also helping large pharmaceutical companies improve their treatments.
Computational method for screening drug compounds can help predict which ones will work best against tuberculosis or other diseases.
Biological engineer discusses condensing the time taken to develop therapeutics down from many years to a matter of months.
Each recipient will receive a $625,000, no-strings-attached award.
Dwaipayan Banerjee’s new book examines the psychological and social terrain of living with cancer in a country where the disease has long been downplayed.
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.